Precision Trials: Navigating the Complexity of Immuno-Oncology
Immuno-oncology (I-O) therapies represent one of the boldest frontiers in cancer treatment, but running I-O trials is inherently complex. These […]
Immuno-oncology (I-O) therapies represent one of the boldest frontiers in cancer treatment, but running I-O trials is inherently complex. These […]
In clinical development, time lost is progress delayed. One of the largest bottlenecks in getting a trial underway is the